BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2. magna-neurologica [Internet]. 2026 Jul. 15 [cited 2026 Jul. 16];4(2):175-86. Available from: https://journal.uns.ac.id/index.php/magna-neurologica/article/view/3308